Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DAWNZERA™ (donidalorsen) safely and effectively. See full prescribing information for DAWNZERA. DAWNZERA™ (donidalorsen) injection, for subcutaneous use Initial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
DAWNZERA™ is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
- generic_name
- donidalorsen
- product_names
- donidalorsen
- ndc
- 71860-103, 71860-103-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en